Skip to main content

Immunodeficiency and Autoimmunity


  • Primary immunodeficiencies (PIDs) are also known as inborn errors of immunity
  • ASCIA Immunoglobulin Replacement Therapy (IRT) and Subcutaneous Immunoglobulin (SCIg) information is mostly not specific for PID, and can be used by other medical specialties. 
Information for Health Professionals

ASCIA Immunodeficiency e-training courses - PID, IRT, HAE

ASCIA Immunodeficiency Strategy for Australia and New Zealand 

ASCIA Newborn Screening for Severe Combined Immune Deficiency (SCID) and BCG Vaccination Position Statement 

ASCIA Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline

ASCIA PID Clinical Update 

References - Immunodeficiency

ASCIA ID Register How to access information (available to ASCIA members only)

Immunoglobulin Replacement Therapy (IRT) 

ASCIA Position Statement - IRT in PID 

ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT - Document currently under review

ASCIA Transfer Care Plan for patients on IRT

Subcutaneous Immunoglobulin (SCIg)

ASCIA SCIg Checklists - Nurse Competency and Patient Training 

ASCIA SCIg Treatment Plan

ASCIA Travel Plan for patients on SCIg

ASCIA SCIg Position Statement  

ASCIA Guide – Setting up a SCIg program in a hospital

Hereditary Angioedema (HAE)

ASCIA HAE Position Paper and Management Plan 

References - HAE

ASCIA Webinar - HAE


ASCIA Position Paper - Laboratory Tests for Autoimmune Diseases 

Information about Vasculitis is available at

Further Information

Webpage updated May 2024